| (E) |   1. | Gastroesophageal reflux disease (GERD) ¬Û·í±`¨£¡A¨ä¦U¶µ¬ÛÃö±Ôz¡A¦óªÌ¿ù»~¡H | 
| A. | ªø´Á«y¹ÂªÌÀ³ÃhºÃ¬O§_¦³GERD | 
| B. | Y¯f±w¦³GERD¤§¯gª¬¡A¦ý¤ºµøÃè¬Ý¤£¥X¹¹DÖß½¤¦³ÅܤơA24¤p®Éesophageal pH recording¦³§U©ó½T¥ß¶EÂ_ | 
| C. | Y¯f±w¦³GERD¤§¯gª¬¡A¦ý¤ºµøÃè¬Ý¤£¥X¹¹DÖß½¤¦³ÅܤơA¥i°µ¹¹D¤Á¤ù¡A¨ä¦ì¸mÀ³¦blower esophageal  sphincter (LES) ¤W¤è5¤½¤À¥ª¥k | 
| D. | Y¯f±w¦³GERD¤§¯gª¬¡A¨Ï¥Îproton pump  inhibitor ( PPI) ªvÀø¤@¶g¦Ó¯gª¬¦³©ú Åã§ïµ½¡A¹ï¶EÂ_¤§½T¥ß¬Û·í¦³À°§U | 
| E. | Y¯f±w¦³GERD¤§¯gª¬¡A¦ý¤ºµøÃè¬Ý¤£¥X¹¹DÖß½¤¦³ÅܤơA±Ä¥ÎBernstein test¹ï¶EÂ_¨S¦³À°§U
 | 
|   | 
| (D) |   2. | Ãö©óZollinger-Ellison syndrome¤§±Ôz¡A¤U¦C¦U¶µ¦óªÌ¿ù»~¡H | 
| A. | ·í¼ìºÅ¥X²{©ó¤Q¤G«ü¸z²Ä¤G³¡¤À¥H¤U®É¡AÀ³¦Ò¼{¬O§_¦³gastrinoma | 
| B. | ¦¹Ãþ¯f±w50%¥i¯à·|¦³¸¡Âm¯gª¬ | 
| C. | Multiple Endocrine Neoplasia (MEN) type I ±wªÌ¬ù25%·|¦³gastrinoma | 
| D. | G²G¤§»ÄÆP«×¡ABAO¡]°ò¦ª¬ºA¡^¡þMAO¡]ª`®gpentagastrin«á¡^< 0.6 | 
| E. | Octreoscan¹ï©óprimary©Îmetastatic gastrinoma¤§°»´ú±Ó·P«×¬Ò¦³¤¤¤Wµ{«×¤§®Ä¯q | 
|   | 
| (B) |   3. | Ãö©ó¦å¤¤amylase¤§À³¥Î¡A¤U¦C±Ôz¦óªÌ¿ù»~¡H | 
| A. | ¹ï«æ©Ê¯ØÅ¦ª¢¤§¶EÂ_¡Aamylase¤§isoenzyme¡]¯S§O¬O P isoamylase¡^¸û¬°specific | 
| B. | ¯ØÅ¦¬O°ß¤@§t¦³trypsinogen¤§¾¹©x¡A¦]¦¹¡AY¦å¤¤trypsinogen¼ÆÈ²§±`¤É°ª¡A¤@©w¦³«æ©Ê¯ØÅ¦ª¢ | 
| C. | ¦³hypertriglyceridemiaªº¤H¡A¿©±w«æ©Ê¯ØÅ¦ª¢®É¡A¨ä¦å¤¤amylase¼ÆÈ¥i¯à¥¿±` | 
| D. | Intestinal obstruction©Îinfarction¥ç¥i¯à¾ÉP¦å¤¤amylase¼ÆÈ²§±`¤É°ª | 
| E. | ´ú¶q§¿¤¤ªºamylase¡A¦p¡Gamylase / creatinine clearance ratio¡A¨Ó¶EÂ_«æ©Ê¯ØÅ¦ª¢¡A¨äsensitivity¤Îspecificity¨Ã¤£¤ñ¦å¤¤amylase¼ÆÈ§ó¦n | 
|   | 
| (A) |   4. | Ãö©ó¸¡Âm¡]diarrhea¡^¤§±Ôz¡A¤U¦C¦U¶µ¦óªÌ¿ù»~¡H | 
| A. | Secretory diarrhea¤§¯SÂI¬°¡G¤ôª¬¡B¤j¶q¤§±Æ«K¡A³q±`µL¸¡µh¡A¥B©óªÅ¸¡«á§Y·|°±¤î | 
| B. | Enterotoxin¾ÉP¤§¸¡Âm¡A±wªÌ³q±`¤£·|µo¿N | 
| C. | Preformed toxin¤Þ°_¤§¸¡Âm¡A¼ç¥ñ´Á³Ìµu¡A¬ù¬°8-24¤p®É | 
| D. | «æ©Ê¸¡Âm90%¥H¤W«Y¥Ñinfectious agents©Ò¤Þ°_¡FºC©Ê¸¡Âm«h¦h¥Ñ«D·P¬V©Êì¦]©Ò¾ÉP | 
| E. | Pseudodiarrhea«Y«ü±Æ«K¦¸¼Æ¼W¥[¡A¦ý¨C¦¸±Æ«Kªº¶q¤£¦h¡]< 200 g/day¡^¡A³oºØ±¡§Î±`¦ñÀHirritable bowel syndrome©Îproctitisµ¥¨zªùªþªñ¤§¯fªp | 
|   | 
| (B) |   5. | Ãö©óIrritable Bowel Syndrome¡]IBS¡^¤§±Ôz¡A¤U¦C¦U¶µ¦óªÌ¿ù»~¡H | 
| A. | IBS¦³¨âºØ¥DnÃþ«¬¡A¤@ºØ¥H¸¡Âm¬°¥Dnªí²{¡A¥t¤@ºØ«h¬°«K¯µ©M¸¡Âm¥æ´À¥X²{ | 
| B. | ¦¹Ãþ¯f±w·|¦³¸¡µh©Î¸¡³¡¤£¾A¡A¸¡µhµo¥Í³¡¦ì±`«]©ó¤W¸¡³¡ | 
| C. | ¦¹Ãþ¯f±w¤§¸¡µh³q±`©ó±Æ«K«á·|¸Ñ°£ | 
| D. | ¸¡µh¤§µo§@±`»P±Æ«KÀW²v¡]stool frequency¡^¤§§ïÅܦ³Ãö | 
| E. | ¸¡µh¤§µo§@±`»P¤j«K©Ê½è¡]stool form¡^¤§§ïÅܦ³Ãö | 
|   | 
| (C) |   6. | ¹ï©óÃhºÃ¦³intestinal obstruction¤§±wªÌ¡A¸¡³¡¢æ¥ú·Ó¬Û¡]plain abdomen¡^¥i´£¨Ñ¬Û·í¦³¥Îªº¸ê®Æ¡C¤U¦C¦U¶µ±Ôz¡A¦óªÌ¿ù»~¡H | 
| A. | Plain abdomen¥Î¨Ó§PÂ_nonstrangulating complete small-bowel obstruction¬Û·í¥i¾a | 
| B. | Partial mechanical small-bowel obstruction»Padynamic ileus¤£¤Ó®e©ö°Ï¤À¡A¦ýcolonic distension¦badynamic ileus³q±`¸û©úÅã | 
| C. | µÈ¤jªº¤p¸z¤¤¥i¨£air-fluid levels¡A±`±Æ¦C¦¨¡§stepladder¡¨ pattern¡A¤Ö¨£¤º§tªÅ®ðªº¤j¸z¡A³o¨Çµo²{±`¨£©óstrangulating small-bowel obstruction | 
| D. | YÁ{§É¯gª¬«Ü¹³small intestine obstruction¡A¦ýplain abdomen¬Ý°_¨Ó¥¿±`¡A¦¹®É¦w±Æ¸¡³¡CTÀˬd¦³§U©ó¶EÂ_ | 
| E. | ³Ü¾X¾¯¨ÓÀ°¦£§PÂ_¤p¸zªºªý¶ë³¡¦ì¬O¬Û·í¦w¥þªº | 
|   | 
| (C) |   7. | Ãö©óºC©ÊC«¬¨xª¢¤§ªvÀø¡A¤U¦C±Ôz¦óªÌ¿ù»~¡H | 
| A. | Interferon £\ ¦X¨ÖRibavirin¤§²Õ¦XÀøªk¬O¥Ø«e¨Ï¥Îªº¥Dn¤è¦¡ | 
| B. | ²Õ¦XÀøªk¹ïHCV genotype 2/3¤§®ÄªGÀu©ó¹ïgenotype 1¤§®ÄªG | 
| C. | Ribavirin¤£¥i¥Î©ó¦³«aª¬°Ê¯ß¤ßŦ¯f±wªÌ¡A¦ý¥i¥Î©óµÇ¥\¯à¤£¥þ¤§±wªÌ | 
| D. | ºC©ÊC«¬¨xª¢±wªÌ¤w¥X²{¨x¥\¯à¤£¥þ¡]decompensation¡^®É¡A¤£¾A¥Î²Õ¦XÀøªk | 
| E. | ¦å¤pªO¤Î¥Õ¦å²y¼Æ¥Ø°§C¬OInterferon £\ ±`¨£ªº°Æ§@¥Î | 
|   | 
| (B) |   8. | ¤U¦C¦UºØ¯e¯f¡A¦b¤fµÄ¤º¡B¥~¥i¯à·|¦³¯f¨_¡C½Ð°Ý¨ä¤¤¨º¤@Ó¯e¯fªº±wªÌ¡A¨ä¥þ¨¥Ö½§¤W¤]·|¦³¼sªxªº¦â¯À¨HµÛ¡H | 
| A. | Leukoplakia | 
| B. | Addison's disease | 
| C. | Osler-Rendu-Weber syndrome ( Hereditary Telangiectasia ) | 
| D. | Heavy metal pigmentation | 
| E. | Peutz-Jeghers syndrome | 
|   | 
| (D) |   9. | ¤@¦ì¯f¤H¦]¶À¯n¦í°|¡A¤§«e±qµL¥k¤W¸¡µhªº¯f¥v¡A¨Åé¶E¹î®ÉºN¨ìµÈ¤jªºÁxÅn¡C¤U¦C¦óªÌ³Ì²Å¦X¦¹µ¥¯f±¡¡H | 
| A. | Impaction of distal CBD stone | 
| B. | Compression of common hepatic duct | 
| C. | Pancreatic neck cancer | 
| D. | Papilla vater cancer | 
| E. | Intrahepatic stone | 
|   | 
| (C) |  10. | ¤@¦ìºC©ÊB«¬¨xª¢¤§±wªÌ¦í°|¡A¨ä©â¦åÀËÅ礧µ²ªG¦p¤U¡GBilirubin(T)/(D)=2.8/2.2¡]<=1.0/<=0.4¡^mg/dL¡AGOT=430¡]<37¡^¡AGPT=  410¡]<41¡^¡AAlkalinephosphatase=720¡]<=220¡^¡A£^-GT=420¡]<=50¡^¡C½Ð°Ý¤U¦C¦óªÌ¥¿½T¡H1. ³o¦ì¯f¤H¤w¸g¥X²{¨x¥\¯à°I°h¡]decompensation¡^ªº±¡ªp¡C2. ³o¦ì¯f¤H¤§¯f±¡²Å¦XºC©ÊB«¬¨xª¢«æ©Êµo§@¡]acute exacerbation¡^¡C3. Prothrombin time¤§ÀËÅç¬O¦³¥²nªº¡C4. À³°¨¤W¦w±Æ¸¡³¡¶WµªiÀˬd¡C5. À³¥J²Ó¸ß°Ý¨ä³Ìªñ¬O§_¦³¥k¤W¸¡µh¡C | 
| A. | 1 + 2 + 3 | 
| B. | 2 + 3 + 4 | 
| C. | 3 + 4 + 5 | 
| D. | 4 + 5 + 1 | 
| E. | 5 + 1 + 2 | 
|   | 
| (E) |  11. | Ãö©ó«DÃþ©T¾J§Üµoª¢ßÓª«¡]NSAID¡^¾ÉPªºG¸z¹D¨Öµo¯g¡A¤U¦C±Ôz¦óªÌ¿ù»~¡H1. ÄY«ªºNSAID¾ÉPªº¨Öµo¯g¡A¤j¦h¼Æ¯f±w©ó¿©¯f«eÀ³¦³dyspepsia¡C2. §C¾¯¶q¡]<=75 mg/d¡^Aspirin¤£·|¾ÉPÄY«ªº¨Öµo¯g¡C3. ¦~¬ö¤j¡A¹L¥h¦³®ø¤Æ©Ê¼ìºÅ¡A¦P®ÉªA¥Î§tÃþ©T¾J¤§ßÓª«¡A¬Ò¬Oestablished risk factor¡C4. Y¦³risk factor¦Ó¤´»ÝªA¥ÎNSAID¡A¥i¥Hproton pump inhibitors©Îmisoprostol¹w¨¾G¸z¹D¨Öµo¯g¡C5. YNSAID¤w³y¦¨G¼ìºÅ¡A¦ý¤S¤£¯à°±¥Î¡A¥i¥ÎH2 blockerªvÀø¡C | 
| A. | 1 + 3 + 5 | 
| B. | 1 + 2 + 4 | 
| C. | 2 + 3 + 4 | 
| D. | 3 + 4 + 5 | 
| E. | 1 + 2 + 5 | 
|   | 
| (E) |  12. | ¤U¦C¦³Ãö¸zô½¤´`Àô»Ùꤧ±Ôz¡A¦óªÌ¦³»~¡H | 
| A. | Arterial embolus»PºC©Êatrial fibrillation¦³Ãö | 
| B. | Arterial thrombosis»Patherosclerosis¦³Ãö | 
| C. | Venous occlusion»Poral contraceptives¦³Ãö | 
| D. | Non-occlusive ischemia»Phypotension¦³Ãö | 
| E. | Abdominal angina»PªÅ¸¡¸¡µh¦³Ãö | 
|   | 
| (B) |  13. | ¤U¦C¦³Ãö·P¬V©Ê¹¹Dª¢¤§±Ôz¡A¦óªÌ¬°»~¡H | 
| A. | ³æ¯Â¯p¯l¯f¬r¹¹Dª¢¦b»ó¤Î¼L®B±`¦³úO¯l | 
| B. | ±aª¬¯p¯l¯f¬r¹¹Dª¢©öµo¥Í©ó¿é¦å±wªÌ | 
| C. | ¥¨²ÓM¯f¬r¹¹Dª¢¶}©l®É¼ìºÅ¬O°Ë¦æ©Ê¡]serpiginous¡^ | 
| D. | HIV¹¹Dª¢¦p¦³²`¼s¼ìºÅ¡A¶·¥ÎÃþ©T¾JªvÀø | 
| E. | ©À¯]µß¹¹Dª¢¦³¦hµo©Ê¶À¦â¬ð°_ªº´³¶ô | 
|   | 
| (D) |  14. | ¤Q¤G«ü¸z¼ìºÅ±wªÌ¤§¯f²z¥Í²z¾Ç¤W¤§±Ôz¡A¦óªÌ¦³»~¡H | 
| A. | ©]¶¡¤ÀªcG»Ä¼W¥[ | 
| B. | ¤Q¤G«ü¸z HCO3- ¤Àªc´î¤Ö | 
| C. | ¤é¶¡G»Ä¤Àªc¼W¥[ | 
| D. | G¿E¯À±Ó·P©Ê°§C | 
| E. | ¶º«áG¿E¯ÀÄÀ©ñ¼W¥[ | 
|   | 
| (D) |  15. | ¤U¦C¯e¯f¡A¦óªÌ¨äSerum-ascites albumin concentration gradient¤p©ó1.1 g/dL¡H | 
| A. | Cirrhosis | 
| B. | Congestive heart failure | 
| C. | Massive hepatic metastasis | 
| D. | Nephrotic syndrome | 
| E. | Acute fatty liver of pregnancy | 
|   | 
| (E) |  16. | ¹¹D¹B°Ê§ÎºAÅã¥Ü¥·Æ¦Ù³¡¥÷¥¿±`¦Ó°©Àf¦Ù³¡¥÷¦¬ÁYÀ£´T«×°§C¡A¨ä¥i¯à¶EÂ_¬°¡G | 
| A. | Viral esophagitis | 
| B. | Scleroderma | 
| C. | Achalasia | 
| D. | Diffuse esophageal spasm | 
| E. | Pharyngeal paralysis | 
|   | 
| (A) |  17. | Whipple's disease (intestinal lipodystrophy ) ¤§±Ôz¡A¦óªÌ¬°»~¡H | 
| A. | ¬°¿ò¶Ç©Ê¯e¯f¡A¦nµo©ó¤¤¦~¥Õ¤H¨k©Ê | 
| B. | ªø´Á¸¡Âm¡AÀç¾i¤£¨} | 
| C. | ¦³¦hµo©ÊÃö¸`ª¢ | 
| D. | ¦³¤¤¼Ï¯«¸g¯gª¬¡A¦pÀYµh¡B½Æµø | 
| E. | ªvÀø¨Ï¥Î§Ü¥Í¯À | 
|   | 
| (E) |  18. | ¤U¦CßÓª«¡A¦óªÌÀ³¤£·|¨Öµo«æ©Ê¯ØÅ¦ª¢¡H | 
| A. | Azathioprine | 
| B. | Sulfonamides | 
| C. | Thiazide diuretics | 
| D. | Tetracycline | 
| E. | Anticholinergics | 
|   | 
| (E) |  19. | ¤U¦C±¡ªp¦p¦X¨Ö¨Ï¥ÎNSAIDs¡A¥i¯à»¤µoG¤Q¤G«ü¸z¼ìºÅ¡A°£¤F | 
| A. | ¦~¦Ñ | 
| B. | ¨Ï¥ÎGlucocorticoids | 
| C. | ¨Ï¥Î¦hºØNSAIDs | 
| D. | ¨Ï¥ÎAnticoagulants | 
| E. | ¨Ï¥ÎProstaglandin | 
|   | 
| (E) |  20. | ¤U¦C¬°Zollinger-Ellison syndrome¤§¼v¹³Àˬd¤¤¡A±Ó·P«×³Ì°ªªº¬O | 
| A. | ¶Wµªi | 
| B. | CT Scan | 
| C. | Selective angiography | 
| D. | MRI | 
| E. | Endoscopic ultrasonography | 
|   | 
| (B) |  21. | ¤U¦CÁx¹Dµ²¥Û¤§§Î¦¨¦]¯À¡A¦óªÌ¬°¦â¯Àµ²¥Û¤§¦¨¦]¡H1. Prolonged parenteral nutrition.2. Chronic hemolysis.3. Alcoholic cirrhosis.4. Chronic biliary tract infection.5. Fasting. | 
| A. | 1 + 2 + 3 | 
| B. | 2 + 3 + 4 | 
| C. | 3 + 4 + 5 | 
| D. | 1 + 3 + 4 | 
| E. | 2 + 4 + 5 | 
|   | 
| (E) |  22. | ¤U¦C¦³ÃößÓª«¤Þ°_¨x¯f¤§±Ôz¡A¦óªÌ¬°«D¡H1. Acetaminophen¹L¶q¤§ªvÀø¡A¨Ï¥ÎN-acetylcysteine¡C2. Amiodarone¥iµo¥ÍÃþ¦ü¯f¬r©Ê¨xª¢¯f²zÅܤơC3. Phenytoin ¥iµo¥Ísteatohepatitis¡C4. INH¨Ö¥ÎRifampicin¡A¨x¬r©Ê¼W¥[¡C5. Oral contraceptives¥iµo¥Ícholestasis¤Îportal inflammation¡C | 
| A. | 1 + 2 + 3 | 
| B. | 2 + 3 + 4 | 
| C. | 3 + 4 + 5 | 
| D. | 1 + 3 + 5 | 
| E. | 2 + 3 + 5 | 
|   |